17 out 2014 ano - FDA approved new labeling for Embeda (morphine sulfate and naltrexone hydrochloride), an extended-release (ER) opioid analgesic to treat pain severe enough to require daily, around-the- clock, long-term opioid treatment and for which alternative treatment options are inadequate.

Adicionado na linha do tempo:

Opioids and the FDA

ByAnastasia

13 nov 2018

0

0

520

Data: